The trademark application CellCompDx was filed by Cellphenomics GmbH, a corporation established under the laws of the Federal Republic of Germany (the "Applicant"). Application refused.
The application was filed in German (English was selected as the second language).
Change of name and address of the trademark registration was recorded on June 7, 2022. Change of name and professional address of the trademark registration was recorded on January 12, 2023.
The Appeal with reference B R2571/2022-2 was Application rejected according to Article 7(1)(b) EUTMR with decision issued on May 22, 2023 by the EUIPO. The Refusal with reference B 018687445 was Rejected according to Article 7(1)(b) EUTMR with decision issued on November 7, 2022 by the EUIPO. The null with reference B T-512/23 was Decision confirmed according to Article 7(1)(b) EUTMR with decision issued on May 14, 2024 by the EUIPO.
Goods And Services
The mark was filed in class 1 with following description of goods:
Industrial chemicals
Chemicals used in science
Biological tissue cultures, other than for medical or veterinary purposes
Biological preparations, other than for medical or veterinary purposes
Reconstituted cells for the tolerance testing of pharmaceutical products
Reconstituted cells for the efficiency testing of pharmaceutical products.
The mark was filed in class 5 with following description of goods:
Biological tissue cultures for medical purposes
Biological tissue cultures for veterinary purposes
Pharmaceutical preparations for the treatment of immune system related diseases and disorders
Chemico-pharmaceutical preparations
Pharmaceuticals
Veterinary preparations
Biological preparations for the treatment of cancer
Biological preparations for veterinary purposes
Biological preparations for medical purposes.
The mark was filed in class 9 with Interactive electronic publications.
The mark was filed in class 41 with following description of goods:
Publishing of medical publications
Publishing scientific papers in relation to medical technology
Publishing and issuing scientific papers in relation to medical technology.
The mark was filed in class 42 with following description of goods:
Inspection of pharmaceuticals
Medical research in the field of oncology
Science and technology services
Providing medical and scientific research information in the field of pharmaceuticals and clinical trials
Testing of pharmaceuticals
Services for assessing the efficiency of pharmaceuticals
Conducting clinical trials for pharmaceutical products
Biomedical research services
Consultancy relating to pharmaceutical research and development
Analysis of human tissues for medical research
Laboratory research services relating to pharmaceuticals
Scientific research for medical purposes in the area of cancerous diseases
Cell culture services for scientific and research purposes, for others
Design and development of medical technology
Design and development of computer software for use with medical technology
Scientific testing services
Pharmaceutical product evaluation
Computer aided diagnostic testing services
Development of measuring and testing methods
Preparation of reports relating to scientific research
Medical laboratory services
Veterinary laboratory services.
The mark was filed in class 44 with following description of goods:
Medical services relating to the removal, treatment and processing of human cells
Medical treatment using cultured cells
Medical services in the field of oncology
Providing on-line information relating to oncology
Medical laboratory services for the analysis of samples taken from patients
Services for the preparation of medical reports
Medical services for the treatment of skin cancer
Medical laboratory services for the analysis of blood samples taken from patients
Medical analysis services
Animal healthcare services
RNA or DNA analysis for cancer diagnosis and prognosis.